Specialty Pharmacy

Blood test quickly and accurately identifies genetic mutations linked to non-small cell lung cancer.

Key factor helps drive metastases in aggressive cancers.

Rinku A. Patel, PharmD, RPh, discusses how to improve communication among patients, physicians, pharmacists, and payers.

Interstitial lung disease, a common complication of rheumatoid arthritis, often leads to deteriorating health.

The Hematology Oncology Pharmacy Association (HOPA) is hosting the HOPA Policy Summit on Drug Waste in the Treatment of Cancer with health care professionals and industry members.

The FDA has approved Aurobindo Pharma’s generic version of olmesartan medoxomil and hydrochlorothiazide tablets in 20 mg/12.5 mg, 40 mg/12.5 mg, and 40 mg/25 mg doses.

The transition to value-based reimbursement is likely to shape the future of health care.

Study provides first direct evidence of HIV persistence in tissue macrophages in vivo, which could lead to a cure for HIV.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can best position themselves to access limited distribution drugs.

Fingolimod (Gilenya) reduced disease progression in patients with relapsing-remitting multiple sclerosis.

Cerliponase alfa (Brineura) is the first treatment approved to treat a form of Batten disease.

Top news of the week in oncology and cancer drug development.

A patient discusses the struggle of receiving treatment for triple negative breast cancer in a rural community.

Major life events regarding close personal relationships may play a role in mortality.

Statins could be used as adjuvant therapy to prevent decompensation, study suggests.

Top five articles of the week from Specialty Pharmacy Times.

Midostaurin demonstrated a statistically significant improvement in overall survival among AML patients.

Top news of the day from across the health care landscape.

Stakeholders across the care landscape, including long-term care pharmacies, specialty pharmacies, and home infusion pharmacies, gather to discuss challenges and opportunities.

Stivarga is the first FDA-approved treatment for hepatocellular carcinoma in almost a decade.

Numerous opportunities for networking exist at the annual Asembia Specialty Pharmacy Summit.

A reduction in the release of serotonin and dopamine may cause chemotherapy-related cognitive decline.

Positivity interventions may influence health outcomes in people living with HIV.

High levels of the Cd14 gene increases gut barrier integrity.

Top news of the day from across the health care landscape.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies will be impacted by the growth of accountable care organizations.

Unexpected survival gains observed in glioblastoma patients administered an investigational dendritic cell vaccine and temozolomide.

Cholesterol-lowering drug approved in once-monthly 300 mg dosing option.